Company / Free Cash Flow per Share
enGene Holdings Inc. Free Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.97
FY2025
5-year range
-$36.18 / -$1.30
FY2022-FY2025
Trend
-51.3%
vs FY2024
Sector context
#131 of 191
Health Care
What the data says
At $-1.97, enGene Holdings Inc.'s free cash flow per share ranks #131 of 191 in the Health Care sector. Improved from $-36.18 to $-1.97 over the past 2 years.
Based on SEC 10-K filings.
-1.97 in FY2025.
Improved from $-36.18 to $-1.97 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 191 in Health CareTop 69% of 191This company -$1.97 Sector average -$24.68
▼
+92.0% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 51.3% year-over-year.
- Ranks #131 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.97 | -51.3% |
| FY2024 | -$1.30 | +96.4% |
| FY2023 | -$36.18 | -33.6% |
| FY2022 | -$27.09 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026